The journal welcomes submissions across — but not limited to — the following areas:

• Head and neck oncology: diagnosis, staging, and multimodal treatment strategies
• Otolaryngology, rhinology, and laryngology: clinical and translational research
• Oral and maxillofacial surgery, reconstructive and aesthetic procedures
• AI-assisted diagnostics and imaging informatics in head and neck pathology
• Thyroid and parathyroid disease: endocrine surgery and management
• Digital health technologies and telemedicine applications in ENT practice
• Epidemiology and public health burden of head and neck diseases
• Rehabilitation, swallowing function, voice disorders, and quality of life outcomes
• Genomics and molecular biomarkers in head and neck cancer

• Original Research — Empirical studies reporting novel clinical or translational findings
• Systematic Review & Meta-Analysis — Rigorous synthesis of existing evidence
• Methods & Technology — Novel surgical techniques, instruments, or diagnostic tools with validation
• Clinical Case Report — Informative case studies with clear educational and clinical value
• Perspective & Commentary — Expert views on emerging clinical topics or health policy
• Data Descriptor — Detailed descriptions of curated, openly available clinical datasets

All submissions undergo single-anonymous peer review conducted by at least two independent domain experts. The editorial board is committed to transparent, constructive, and timely review — target first decision within 6 weeks of submission.

Head and Neck Diseases Conflux adheres to COPE (Committee on Publication Ethics) guidelines and requires all clinical research to comply with applicable ethical standards and reporting guidelines (CONSORT, STROBE, PRISMA, CARE, etc.).